Melatonin, a calpain inhibitor in the central nervous system: Current status and future perspectives.
Omid Reza TamtajiNaghmeh MirhosseiniRussel J ReiterAbolfazl AzamiZatollah AsemiPublished in: Journal of cellular physiology (2018)
Dysregulation of neuronal Ca2+ and oxidative stress plays an important role in the activation of cysteine proteases including calpains and caspases that contribute to neuronal death. In neurodegenerative diseases, traumatic brain injury, stroke, and neuropathic pain calpain activities are markedly increased. Melatonin is a beneficial supplement in the treatment of central nervous system (CNS) disorders. Melatonin is a potent antioxidant and works as a free-radical scavenger to regulate a large number of molecular pathways, including oxidative stress, inflammation, apoptosis, and cell death under different pathological conditions. However, limited studies have evaluated the inhibitory effect of melatonin on calpains. This review summarizes the current knowledge related to the effects of melatonin on calpains in some of the common CNS disorders.
Keyphrases
- oxidative stress
- neuropathic pain
- cell death
- traumatic brain injury
- ischemia reperfusion injury
- diabetic rats
- current status
- dna damage
- induced apoptosis
- spinal cord injury
- spinal cord
- cell cycle arrest
- blood brain barrier
- anti inflammatory
- endoplasmic reticulum stress
- cell proliferation
- living cells
- severe traumatic brain injury